Research ArticleCancer

mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in PIK3CA-Mutant Breast Cancer

See allHide authors and affiliations

Science Translational Medicine  31 Jul 2013:
Vol. 5, Issue 196, pp. 196ra99
DOI: 10.1126/scitranslmed.3005747

Log in to view PDF

Log in through your institution

Log in through your institution